Medindia

X

Inverness Medical Innovations Announces September Investor Conference Schedule

Thursday, September 17, 2009 General News J E 4
Advertisement
WALTHAM, Mass., Sept. 10 Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend several healthcare industry investor conferences during the month of September.

During their presentations, Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcasts, may contain or constitute information that has not been disclosed previously. Replays of the webcasts will be available via the links indicated above for 30 days.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

-- Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend the Morgan Stanley Global Healthcare Conference being held on September 14 and 15, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central. Mr. Zwanziger's presentation is scheduled for Monday, September 14, 2009 at 2:45 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the Morgan Stanley Conference website at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=IMA&item_id =2400719. -- Mr. Zwanziger and Mr. Russell will attend the Stifel Nicolaus/Johns Hopkins Annual Healthcare Symposium being held at the Hilton, Baltimore, Maryland on Tuesday, September 15, 2009. This symposium will not be webcast. -- Mr. Russell will attend ThinkEquity's 6(th) Annual Growth Conference being held at the St. Regis, San Francisco on Wednesday, September 16. Mr. Russell's presentation is scheduled for 9:30 a.m., and will not be webcast. -- Mr. Zwanziger and Mr. Russell will attend the UBS Global Life Sciences Conference being held on September 21 through the 23, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central. Mr. Zwanziger's presentation is scheduled for Tuesday, September 22, 2009 at 11:30 a.m. and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the UBS Conference website at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=143_EFSBJ3O.

SOURCE Inverness Medical Innovations, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
JHD Group Announces TURNKEY EHR(TM) Service
S
Reportlinker Adds US and European Radiopharmaceuti...